Quick Takeaways: Why It Matters? Automation on the IDS i10 platform lets Volition scale Nu.Q Vet testing volume and speed, making routine cancer screening more practical for large hospital networks. Deeper integration with Fujifilm Vet Systems in Japan also stren...
Quick Takeaways: Why It Matters? MUMS status gives Masivet a clearer US regulatory and commercial path, adding potential 7‑year market exclusivity and grant support on top of its established European use, which should enhance the asset’s value as AB Science courts par...
Quick Takeaways: Why It Matters? By expanding Cancer Dx and inVue Dx, IDEXX tightens its grip on veterinary oncology workflows, nudging clinics toward proactive, panel-based cancer screening rather than reactive testing. Bundling mast cell detection at no extra c...
